Similarly, another report demonstrated that reduced levels of HDL-C and its primary component, apolipoprotein A-I, were associated with greater disease severity, complications, and poorer survival outcomes in patients with liver failure [49]. The gene discussed is APOA1; the disease is Hepatic failure.